Literature DB >> 437925

Some environmental and bodily characteristics of melanoma patients. A case-control study.

O Klepp, K Magnus.   

Abstract

A case-control study including 78 patients with malignant melanoma of the skin and 131 controls with the diagnoses of malignant lymphoma, testicular cancer or bone and soft-tissue sarcoma, was performed at the Norwegian Radium Hospital 1974-1975. The questionnaire contained questions for evaluating the comparability between cases and controls, and questions bearing on the relation between sun exposure and malignant melanoma. No essential difference between cases and controls was found as regards hair and eye colour, time spent outdoors during leisure, and degree of solar exposure. The melanoma patients liked sunbathing less than controls, worked more outdoors, more often went to Southern Europe for sunbathing and more often used sun lotions. These differences, however, were not clearly statistically significant. Highly significant differences were demonstrated as regards the tolerance of sun exposure and propensity to freckling. The melanoma patients tolerated sun exposure less well and freckled more easily than the controls. Although attempts were made to eliminate bias, there are still limitations and loop-holes in the study, and the relative risks demonstrated are not large enough to be of great immediate practical or scientific value. It seems justified, however, to advise persons with a low sun exposure tolerance to be cautious in following the sun-tan-demanding fashions. The study may also provide certain clues for the planning of future epidemiological and clinical studies regarding the etiology of malignant melanoma.

Entities:  

Mesh:

Year:  1979        PMID: 437925     DOI: 10.1002/ijc.2910230407

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  25 in total

1.  Indoor tanning and risk of melanoma: a case-control study in a highly exposed population.

Authors:  DeAnn Lazovich; Rachel Isaksson Vogel; Marianne Berwick; Martin A Weinstock; Kristin E Anderson; Erin M Warshaw
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-26       Impact factor: 4.254

2.  Analysis of association between sunscreens use and risk of malignant melanoma.

Authors:  Fang Xie; Tingting Xie; Qi Song; Shan Xia; Hengjin Li
Journal:  Int J Clin Exp Med       Date:  2015-02-15

3.  DNA repair synthesis in fibroblast strains from patients with actinic keratosis, squamous cell carcinoma, basal cell carcinoma, or malignant melanoma after treatment with ultraviolet light, N-acetoxy-2-acetyl-aminofluorene, methyl methanesulfonate, and N-methyl-N-nitrosourea.

Authors:  H W Thielmann; L Edler; M R Burkhardt; E G Jung
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

4.  Fluorescent lights, ultraviolet lamps, and risk of cutaneous melanoma.

Authors:  A J Swerdlow; J S English; R M MacKie; C J O'Doherty; J A Hunter; J Clark; D J Hole
Journal:  BMJ       Date:  1988-09-10

Review 5.  Cutaneous malignant melanoma and ultraviolet radiation: a review.

Authors:  J Longstreth
Journal:  Cancer Metastasis Rev       Date:  1988-12       Impact factor: 9.264

6.  The pathogenesis of cutaneous malignant melanoma.

Authors:  R M MacKie
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-26

7.  Recent cohort trends in malignant melanoma by anatomic site in the United States.

Authors:  L K Dennis; E White; J A Lee
Journal:  Cancer Causes Control       Date:  1993-03       Impact factor: 2.506

8.  Site distribution of malignant melanoma.

Authors:  J M Elwood; R P Gallagher
Journal:  Can Med Assoc J       Date:  1983-06-15       Impact factor: 8.262

9.  Pigmentation and skin reaction to sun as risk factors for cutaneous melanoma: Western Canada Melanoma Study.

Authors:  J M Elwood; R P Gallagher; G B Hill; J J Spinelli; J C Pearson; W Threlfall
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-14

10.  A local education campaign on early diagnosis of malignant melanoma.

Authors:  K Hoffmann; T Dirschka; H Schatz; M Segerling; T Tiemann; A Hoffmann; P Altmeyer
Journal:  Eur J Epidemiol       Date:  1993-11       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.